The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...
NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...
The National Institute for Health and Care Excellence (NICE) has approved a one-off gene editing therapy to treat severe sickle cell disease (SCD) in people 12 years and over. In final draft guidance1 ...
Vertex Pharmaceuticals (NASDAQ:VRTX) announced Friday a reimbursement agreement with England’s National Health Service (NHS) ...
President Droupadi Murmu on Friday said the government has accorded top priority to the welfare of tribal people who were ...
Two landmark surveys open in London this month. Donald Rodney, at the Whitechapel Gallery, and Noah Davis, at the Barbican ...